NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE25203 Query DataSets for GSE25203
Status Public on Mar 09, 2012
Title microRNA alterations associated to clinical response in advanced stage ovarian cancer patients (test set)
Organism Homo sapiens
Experiment type Non-coding RNA profiling by array
Summary In order to investigate miRNA alterations associated to early relapse in ovarian cancer patietns, we analyzed miRNA expression profile in a test set of 30 surgical specimens including 13 early and 17 late relapsing patients. Samples included in test set were obtained from formalin-fixed paraffin-embedded (FFPE) specimens.
 
Overall design Patients were selected on the basis of residual disease after primary surgery and time to relapse (TTR) after front-line chemotherapy. For the test set, a selection of the outliers concerning TTR was made: 12 months from the end of therapy was the TTR selected to define early (<12 months) or late (>12 months) relapsing patients.

Clinical codes:

Histotype: according to International Federation of Gynecological and Obstetrics guidelines

Stage: according to International Federation of Gynecological and Obstetrics guidelines

Grading: according to WHO guidelines

Debulking: NED: not evident disease; mRD: minimal residual disease; GRD: gross residual disease

Therapy code: P: Platinum without taxanes; PT: Platinum/paclitaxel

End Point: Early: relapse whithin 12 and 6 months from the end of therapy for optimally (NED+ mRD) and sub-optimally (GRD) debulked patients respectively. Late: median time to relapse 48 and 34 months from the end of therapy for optimally and sub-optimally debulked patients respectively.

Time to relapse (TTR) code: 0=no relapse; 1=relapse

Overall survival (OS) code: 0=alive; 1=dead
 
Contributor(s) De Cecco L
Citation(s) 22246208
Submission date Nov 08, 2010
Last update date Feb 18, 2019
Contact name Loris De Cecco
E-mail(s) loris.dececco@istitutotumori.mi.it
Organization name IRCSS Istituto Nazionale Tumori
Street address via Venezian 1
City Milan
ZIP/Postal code 20133
Country Italy
 
Platforms (1)
GPL8179 Illumina Human v2 MicroRNA expression beadchip
Samples (30)
GSM619196 TM56
GSM619197 TM57
GSM619198 TM58
This SubSeries is part of SuperSeries:
GSE25204 microRNA alterations associated to clinical response in advanced stage ovarian cancer patients
Relations
BioProject PRJNA142791

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE25203_RAW.tar 70.0 Kb (http)(custom) TAR
GSE25203_TestSet_non-normalized.txt.gz 251.0 Kb (ftp)(http) TXT
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap